Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Forsyth, Christopher B ^a   Shannon, Kathleen M ^a   Kordower, Jeffrey H ^b   Voigt, Robin M ^a   Shaikh, Maliha ^a   Jaglin, Jean A ^a   Estes, Jacob D ^c   Dodiya, Hemraj B ^b   Keshavarzian, Ali ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALPHA SYNUCLEIN; BIOLOGICAL MARKER; ENDOTOXIN; LACTULOSE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MANNITOL; SUCRALOSE; 3-NITROTYROSINE; ACUTE PHASE PROTEIN; CARRIER PROTEIN; DRUG DERIVATIVE; ENDOTOXIN, ESCHERICHIA COLI; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; SUCROSE; TRICHLOROSUCROSE; TYROSINE;

ADULT; AGED; ARTICLE; BACTERIAL TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DISEASE ASSOCIATION; DISEASE DURATION; ENDOTOXIN DETECTION; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; ENZYME IMMUNOASSAY; ESCHERICHIA COLI INFECTION; INTESTINE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NERVE CELL; PATHOGENICITY; PATHOLOGY; PERMEABILITY;

ACUTE-PHASE PROTEINS; AGED; ALPHA-SYNUCLEIN; BIOLOGICAL MARKERS; CARRIER PROTEINS; ENDOTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; PERMEABILITY; SUCROSE; TYROSINE;

EID: 82455206282     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028032     Document Type: Article

References (51)

1. Lees AJ, Hardy J, Revesz T, (2009) Parkinson's disease. Lancet 373: 2055-2066.
2. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, et al. (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68: 384-386.
3. Hobson P, Meara J, Ishihara-Paul L, (2010) The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population. J Neurol Neurosurg Psychiatry 81: 1093-1098.
4. Shults CW, (2006) Lewy bodies. Proc Natl Acad Sci U S A 103: 1661-1668.
5. Braak H, Del Tredici K, (2008) Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 70: 1916-1925.
6. Thomas B, Beal MF, (2007) Parkinson's disease. Hum Mol Genet 16 Spec No. 2: R183-194.
7. Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, Bruley des Varannes S, et al. (2009) The second brain and Parkinson's disease. Eur J Neurosci 30: 735-741.
8. Savidge TC, Sofroniew MV, Neunlist M, (2007) Starring roles for astroglia in barrier pathologies of gut and brain. Lab Invest 87: 731-736.
9. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
10. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, et al. (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1: 6ra14.
11. Menard S, Cerf-Bensussan N, Heyman M, (2010) Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 3: 247-259.
12. John LJ, Fromm M, Schulzke JD, (2011) Epithelial barriers in intestinal inflammation. Antioxid Redox Signal.
13. Farhadi A, Banan A, Fields J, Keshavarzian A, (2003) Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 18: 479-497.
14. Braak H, Rub U, Gai WP, Del Tredici K, (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110: 517-536.
15. Hawkes CH, Del Tredici K, Braak H, (2007) Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33: 599-614.
16. Gutsmann T, Muller M, Carroll SF, MacKenzie RC, Wiese A, et al. (2001) Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 69: 6942-6950.
17. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ, (1995) Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 270: 10482-10488.
18. Minter RM, Bi X, Ben-Josef G, Wang T, Hu B, et al. (2009) LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction. Am J Physiol Gastrointest Liver Physiol 296: G45-54.
19. Shannon K, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, jaglin JA, Kordower JH, (2011) Alpha-synuclein in Colonic Submucosa in Early Untreated Parkinson Disease. Movement Disorders In press.
20. Greene JG, Noorian AR, Srinivasan S, (2009) Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease. Exp Neurol 218: 154-161.
21. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ, (1987) Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37: 1253-1255.
22. Qualman SJ, Haupt HM, Yang P, Hamilton SR, (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 87: 848-856.
23. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F, (1988) Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 76: 217-221.
24. Wakabayashi K, Takahashi H, Ohama E, Ikuta F, (1990) Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79: 581-583.
25. Wakabayashi K, Takahashi H, (1997) Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 38 (Suppl 2): 2-7.
26. Lebouvier T, Chaumette T, Damier P, Coron E, Touchefeu Y, et al. (2008) Pathological lesions in colonic biopsies during Parkinson's disease. Gut 57: 1741-1743.
27. Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, et al. (2010) Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 5: e12728.
28. Phillips RJ, Walter GC, Wilder SL, Baronowsky EA, Powley TL, (2008) Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease? Neuroscience 153: 733-750.
29. Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, et al. (2011) Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord.
30. Hirsch EC, Hunot S, (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8: 382-397.
31. Ouchi Y, Yagi S, Yokokura M, Sakamoto M, (2009) Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat Disord 15 (Suppl 3): S200-204.
32. McGeer PL, McGeer EG, (2004) Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci 1035: 104-116.
33. Niehaus I, Lange JH, (2003) Endotoxin: is it an environmental factor in the cause of Parkinson's disease? Occup Environ Med 60: 378.
34. Qin L, Wu X, Block ML, Liu Y, Breese GR, et al. (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55: 453-462.
35. Wang S, Yan JY, Lo YK, Carvey PM, Ling Z, (2009) Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res 1265: 196-204.
36. Whitton PS, (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 150: 963-976.
37. Kitchens RL, Thompson PA, (2005) Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 11: 225-229.
38. Keck S, Muller I, Fejer G, Savic I, Tchaptchet S, et al. (2011) Absence of TRIF Signaling in Lipopolysaccharide-Stimulated Murine Mast Cells. J Immunol 186: 5478-5488.
39. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, et al. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20: 6309-6316.
40. Gao HM, Zhang F, Zhou H, Kam W, Wilson B, et al. (2011) Neuroinflammation and alpha-Synuclein Dysfunction Potentiate Each Other Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson's Disease. Environ Health Perspect.
41. Cirillo C, Sarnelli G, Esposito G, Grosso M, Petruzzelli R, et al. (2009) Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol Motil 21: 1209-e1112.
42. Murakami M, Ohta T, Ito S, (2009) Lipopolysaccharides enhance the action of bradykinin in enteric neurons via secretion of interleukin-1beta from enteric glial cells. J Neurosci Res 87: 2095-2104.
43. Zhang R, Miller RG, Gascon R, Champion S, Katz J, et al. (2009) Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 206: 121-124.
44. Maes M, Kubera M, Leunis JC, (2008) The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29: 117-124.
45. Emanuele E, Orsi P, Boso M, Broglia D, Brondino N, et al. (2010) Low-grade endotoxemia in patients with severe autism. Neurosci Lett 471: 162-165.
46. Davies KN, King D, Billington D, Barrett JA, (1996) Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease. Postgrad Med J 72: 164-167.
47. Hughes AJ, Daniel SE, Kilford L, Lees AJ, (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
48. McOmber ME, Ou CN, Shulman RJ, (2010) Effects of timing, sex, and age on site-specific gastrointestinal permeability testing in children and adults. J Pediatr Gastroenterol Nutr 50: 269-275.
49. Farhadi A, Keshavarzian A, Fields JZ, Sheikh M, Banan A, (2006) Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 836: 63-68.
50. Farhadi A, Keshavarzian A, Holmes EW, Fields J, Zhang L, et al. (2003) Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci 784: 145-154.
51. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, et al. (2010) Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 6.